HAL (France)
open access
CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiation.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- CD22 Targeting CAR-T Therapy Against B Cell Hematological Malignancies#1212804
- Anti-CD19 FasT CAR-T Cell Therapy for B Cell NHL#1046515
- CD69 blockade restores the bone marrow niche and delays leukemogenesis in a mouse model of Nras (G12D)-driven chronic myelomonocytic leukemia.#308904
- Reprogramming RIPK3-induced cell death in malignant B cells promotes immune-mediated tumor control#350582
- Depletion of Regulatory T Cells Induces High Numbers of Dendritic Cells and Unmasks a Subset of Anti-Tumour CD8+CD11c+ PD-1lo Effector T Cells#1133846
Record · ID 1251506
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive